Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

Toragen, Inc. Announces Chief Medical Officer to Drive the Company's Clinical Development


Toragen Inc., a San Diego-based biotechnology company focused on developing, repurposing, and commercializing uniquely selective drugs targeting cancers caused by the human papillomavirus ("HPV"), today announced that Neil Clendeninn, MD, PhD, joined as Chief Medical Officer.

Dr. Clendeninn has worked for over 20 years in the pharmaceutical and biotechnology industry and has an established track record of successful drug development. Most recently Dr. Clendeninn served as the Senior Vice President and Chief Medical Officer of Heron Therapeutics, in San Diego, CA, where he established the clinical departments including Medical Affairs, Clinical Operations, Clinical Research and Biostatistics. He was instrumental in gaining the approval of SUSTOL, a long-acting granisetron formulation for chemotherapy-induced nausea and vomiting. Previously he held the position of Vice President of Clinical Affairs for Agouron Pharmaceuticals, of La Jolla, CA where he helped develop the anti-viral HIV protease inhibitor Viracept (Nelfinavir).

"We are thrilled to welcome Dr. Clendeninn to the Toragen team at such a critical time in our corporate growth," said Dr. Sandra Coufal, Toragen's CEO. "Dr. Clendininn's direct experience in clinical oncology, and his long career in drug development, including anti-virals, is an ideal match for Toragen, and I look forward to his leadership of our Phase I clinical trial."

About Toragen

Toragen, a pre-clinical stage biotechnology company, is targeting the root cause of virally induced cancers. https://toragen.com.


These press releases may also interest you

at 03:05
ADVA today expanded its uCPE solution with Ensemble Cloudlet. This new software is a direct response to the growing demand from enterprises for on-premises cloud solutions. With Ensemble Cloudlet, enterprises can harness edge computing to meet...

at 03:05
LegalOn Technologies ("LegalOn"), the leading legal technology company from Japan, announced its expansion into the United States, the largest legal market in the world, and the appointment of Daniel Lewis as US CEO. "LegalOn has built the world's...

at 03:05
GlobalTrade Corporation (GTC) has announced today that it has been acquired by Swiss headquartered Komgo. Jointly Komgo and GTC provide trade finance digitalisation solutions to over 120 multinational clients and their 11,000+ subsidiaries,...

at 03:01
Lattice, the leading provider of people success software that empowers business leaders to build engaged and high-performing teams and inspire winning cultures, today announced that Mercer Compensation Benchmark data is now available through...

at 03:00
Qorus, a global association for retail financial institutions, and Accenture today announced the winners of the ninth annual Qorus-Accenture Banking Innovation Awards during a live ceremony in Barcelona. The awards serve as a catalyst for...

at 03:00
The TON Foundation have today expressed their faith in a cross-chain future by announcing the connection of the TON (The Open Network) blockchain to Ozys' Orbit Bridge. Orbit Bridge is a cross-chain platform developed by Ozys, one of the leading...



News published on 7 october 2022 at 17:25 and distributed by: